The net vasoconstriction in response to neuropeptide Y (NPY) treatment was greater and the net vasodilation in response to γ-aminobutyric acid (GABA) treatment was attenuated in the WD-AB group (main effect of WD-AB; P < 0.05; Figure 2, A and B). The gene discussed is NPY; the disease is Wilson disease.